학술논문
AZD4320, a dual inhibitor of bcl-2 and bcl-xl , induces tumor regression in hematologic cancer models without dose-limiting thrombocytopenia
Document Type
Article
Author
Balachander, S.B.; Criscione, S.W.; Byth, K.F.; Cidado, J.; Adam, A.; Lewis, P.; Macintyre, T.; Wen, S.; Lawson, D.; Burke, K.; Tabatabai, A.; Tavana, O.; Schuller, A.; Zinda, M.; Secrist, J.P.; Lubinski, T.; Tyner, J.W.; Kurtz, S.E.; McWeeney, S.K.; Varnes, J.; Diebold, R.B.; Gero, T.; Ioannidis, S.; Hennessy, E.J.; Saeh, J.C.; McCoull, W.; Su, N.; Garnett, M.J.; Jaaks, P.; Coker, E.A.; Gregory, G.P.; Newbold, A.; Johnstone, R.W.; Gangl, E.; Gibbons, F.D.; Wild, M.; Davies, B.R.; Fawell, S.E.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, December 2020, 26(24):6535-6549)
Subject
Language
English
ISSN
15573265
10780432
10780432